IL17A, Human (Secukinumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-IL17A, Human (Secukinumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityIL17A, Human (Secukinumab biosimilar)
CloneSecukinumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
Applicationsn/a
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human IL17A Recombinant Antibody (Secukinumab). Secukinumab, sold under the brand name Cosentyx, is a human IgG1 monoclonal antibody that binds to the protein interleukin (IL)-17A, and is marketed by Novartis for the treatment of psoriasis, ankylosing spondylitis, and psoriatic arthritis. It inhibits a member of the cytokine family, interleukin 17A.
Immunogenn/a
Other NamesAnti-IL17A Recombinant Antibody, Research Grade Secukinumab, Anti-Human IL17A Recombinant Antibody(Secukinumab), AIN457, Antibody Drug Analogues, Monoclonal Antibody, YR1220, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1229022-83-6
Catalog #YR1220
Priceplease inquire
Order / More InfoIL17A, Human (Secukinumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.